BMO says Eylea court decision ‘modest negative’ for Regeneron
BMO Capital says that today’s appeals court decision to affirm the denial of Regeneron’s (REGN) preliminary injunction against Amgen (AMGN) in ...
Regeneron down 3% after appeals court decision in Amgen patent fight
EDT Regeneron (REGN) down 3% after appeals court decision in Amgen (AMGN) patent fightLight Up your Portfolio with Spark:Easily identify ...
Struggles Getting Stakeholder Buy-In Slow AI Adoption by In-House Counsel, Users Say
Most organizations have some type of multifunctional committee set up to evaluate generative AI applications. Those ...
Struggles Getting Stakeholder Buy-in Slowing Gen AI Adoption
Most organizations have some type of multi-functional committee set up to evaluate generative AI applications. Those ...